Korea Technology Finance Corporation Selects Promising Bio Companies to Support Global Expansion

by Kim Chulhyun

Published 06 May.2026 09:32(KST)

Agreement Signed with Korea Health Industry Development Institute, Roche Korea, and Basel Investment Agency

Korea Technology Finance Corporation announced on May 6 that it has signed a “Global Open Innovation Agreement” with Korea Health Industry Development Institute, Roche Korea, and Basel Investment Agency to advance the domestic biohealth industry and accelerate its entry into global markets.

This agreement was established to support the innovative growth of promising Korean bio companies and lay the groundwork for their expansion abroad by fostering collaboration between global pharmaceutical companies and relevant domestic and international organizations.

Younghoon Jung, Planning Director of the Korea Health Industry Development Institute (from left), Ezat Azem, CEO of Roche Korea, Joosun Park, Executive Director of Korea Technology Finance Corporation, and Bonggeun Oh, Korea Representative of Basel Investment Agency, along with other participants, are taking a commemorative photo after the business agreement signing. Photo by Korea Technology Finance Corporation

Under the agreement, each organization will establish a cooperative framework focusing on the following: discovering promising domestic bio companies; facilitating the exchange of specialized personnel; linking physical infrastructure and financial support for research, development, and commercialization; and collaborating on clinical and research capabilities.

Additionally, by jointly operating the “Global Open Innovation Program,” the parties plan to provide selected companies with comprehensive support, including research funding, mentoring, assistance with moving into and settling in the Switzerland Innovation Park Basel Area, and enhanced financial measures such as higher guarantee ratios and reduced guarantee fees.

Taking this agreement as an opportunity, the participating organizations aim to enhance the innovation growth capacity of promising bio companies and alleviate their financial burden to boost their competitiveness in overseas markets. Juseon Park, Executive Director at Korea Technology Finance Corporation, stated, “This agreement will serve as a catalyst for domestic bio companies to establish a foundation for sustainable growth and strengthen their competitiveness in the global market.” He added, “Korea Technology Finance Corporation will continue to expand its cooperation with related organizations to further support the scaling up and global expansion of bio venture companies.”